About: Novel coronavirus disease 2019 (COVID‐19) and neurodegenerative disorders

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Novel coronavirus disease 2019 (COVID‐19) and neurodegenerative disorders Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Novel coronavirus disease 2019 (COVID‐19) and neurodegenerative disorders
Creator	Awasthi, Rajendra Singh, Kumar Bhushan, Bharat Maurya, \| Mishra, Gaurav Noida, Uttar Pradesh, India Pradesh, Uttar Santosh, \| Singh, Anurag
Source	Medline; PMC
abstract	During the last few months, the whole humanity is experiencing largest and most severe sudden influx of COVID‐19 outbreak caused by the novel coronavirus (CoV) originated from Wuhan, China. According to the WHO reports, total 3 862 676 positive cases and 265 961 deaths have been recorded worldwide due to COVID‐19 infection as of May 9, 2020. CoVs are a large family of viruses (enveloped, single‐stranded RNA viruses), which includes severe acute respiratory syndrome coronavirus (SARS‐CoV) and Middle East respiratory syndrome‐related coronavirus (MERS‐CoV). New SARS CoV2 is the members of Betacoronavirus genus. These viruses cause infections in bats, camels and humans, and a few other associated species. Despite many neurologic complications associated with SARS‐CoV‐2 infection, it is still unclear whether these symptoms results from direct neural injury or due to some other reason. Currently, it appears that most of the neurological symptoms of COVID‐19 are nonspecific and secondary to the systemic illness. A single case of acute hemorrhagic necrotizing encephalopathy has been reported. SARS‐CoV‐2 associated Guillain‐Barré syndrome is an atypical case. Till today, no convincing evidence is available to confirm that the SARS‐CoV‐2 virus directly affects nerves system in humans. However, postinfection surveillance will be necessary to identify the possible post‐COVID‐19 neurologic syndromes.
has issue date	2020-05-26(xsd:dateTime)
bibo:doi	10.1111/dth.13591
bibo:pmid	32412679
has license	no-cc
sha1sum (hex)	b8f37c5faba86cac9cf3a50032292bb12c488716
schema:url	https://doi.org/10.1111/dth.13591
resource representing a document's title	Novel coronavirus disease 2019 (COVID‐19) and neurodegenerative disorders
has PubMed Central identifier	PMC7261984
has PubMed identifier	32412679
schema:publication	Dermatol Ther
resource representing a document's body	covid:b8f37c5faba86cac9cf3a50032292bb12c488716#body_text
is schema:about of	named entity 'viruses' named entity 'family' named entity 'evidence' named entity 'case' named entity 'necrotizing' named entity 'species' named entity 'SYMPTOMS' named entity 'TODAY' named entity 'NECROTIZING ENCEPHALOPATHY' named entity 'NECESSARY' named entity 'CAUSE' named entity 'ASSOCIATED' named entity 'infection' named entity 'secondary' named entity 'humans' named entity 'May 9' named entity 'genus' named entity 'symptoms' named entity 'dth' named entity 'COVID' named entity 'encephalopathy' named entity 'genus' named entity 'CoV' named entity 'single case' named entity 'SARS-CoV-2 virus' named entity 'family of viruses' named entity 'MERS-CoV' named entity 'SARS-CoV' named entity 'SARS-CoV-2' named entity 'Guillain-Barré syndrome' named entity 'systemic illness' named entity 'SARS-CoV-2' named entity 'RNA viruses' named entity 'COVID-19 infection' named entity 'dth' named entity 'CoV' named entity 'coronavirus' named entity 'coronavirus outbreak' named entity 'neurologic' named entity 'Guillain-Barré syndrome' named entity 'World Health Organization' named entity 'January 8' named entity 'pathogen' named entity 'COVID-19' named entity 'Center for Disease Control and Prevention' named entity 'public health emergency of international concern' named entity 'WHO' named entity 'Coronavirus' named entity 'CNS' named entity 'COVID' named entity 'World Health Organization' named entity 'SARS-CoV-2 virus' named entity 'Wuhan' named entity 'COVID-19 outbreak' named entity 'necrotizing' named entity 'COVID-19' named entity 'Betacoronavirus' named entity 'neurological symptoms' named entity 'COVID-19 outbreak' named entity 'symptoms' named entity 'SARS-CoV-2' named entity 'neurologic' named entity 'BATS' named entity 'NOVEL CORONAVIRUS' named entity 'viruses' named entity 'hemorrhagic' named entity 'coronavirus' covid:arg/b8f37c5faba86cac9cf3a50032292bb12c488716 named entity 'LARGE FAMILY' named entity 'REPORTED' named entity '862' named entity 'ATYPICAL'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software